essentialpharmagroup.com Revenue and Competitors
Estimated Revenue & Valuation
- essentialpharmagroup.com's estimated annual revenue is currently $15.3M per year.
- essentialpharmagroup.com's estimated revenue per employee is $201,000
Employee Data
- essentialpharmagroup.com has 76 Employees.
- essentialpharmagroup.com grew their employee count by 31% last year.
essentialpharmagroup.com Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $41.8M | 208 | 16% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $23.9M | 119 | 0% | N/A | N/A |
#5 | $108.1M | 538 | 14% | N/A | N/A |
#6 | $52.9M | 263 | 13% | N/A | N/A |
#7 | $24.7M | 123 | 13% | N/A | N/A |
#8 | $1.8M | 18 | 13% | $114.3M | N/A |
#9 | $9M | 45 | 7% | N/A | N/A |
#10 | $14.7M | 73 | -11% | N/A | N/A |
What Is essentialpharmagroup.com?
Essential Pharma ensures the sustainable supply of low volume, difficult to manufacture but clinically well-established pharmaceutical products to patients. These branded and generic medicines form an essential part of the pharmacopeia and represent many therapeutic areas. The company is an important partner to healthcare providers by providing medicines that otherwise would not be available. Essential Pharma has worked with many of the largest pharmaceutical companies and key national health service stakeholders to ensure the continued supply of these well-established medicines to patients in as many countries as possible since 2000.
keywords:N/AN/A
Total Funding
76
Number of Employees
$15.3M
Revenue (est)
31%
Employee Growth %
N/A
Valuation
N/A
Accelerator
essentialpharmagroup.com News
For more information, please visit essentialpharmagroup.com. CONTACTS. Essential Pharma Steen Vangsgaard, CEO Tel: +44(0)1784 477 167
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $29M | 95 | 34% | N/A |
#2 | $27M | 110 | 12% | N/A |
#3 | $17.8M | 123 | N/A | N/A |
#4 | $16.2M | 135 | 11% | N/A |
#5 | $27.6M | 178 | 12% | N/A |